The  Glioblastoma Multiforme Treatment Market Industry was valued at USD 2.64 billion in 2022. It is projected to reach USD 5.07 billion by 2030, with a compound annual growth rate (CAGR) of 8.5% during the forecast period from 2023 to 2030. Glioblastoma Multiforme (GBM) is a severe form of brain cancer that requires effective treatment options. The market for GBM treatment is...